1. Home
  2. FDP vs DNTH Comparison

FDP vs DNTH Comparison

Compare FDP & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fresh Del Monte Produce Inc.

FDP

Fresh Del Monte Produce Inc.

HOLD

Current Price

$40.23

Market Cap

1.7B

ML Signal

HOLD

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

HOLD

Current Price

$49.52

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FDP
DNTH
Founded
1886
2015
Country
Employees
N/A
N/A
Industry
Farming/Seeds/Milling
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FDP
DNTH
Price
$40.23
$49.52
Analyst Decision
Strong Buy
Analyst Count
0
10
Target Price
N/A
$71.22
AVG Volume (30 Days)
210.4K
810.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.98%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$1.82
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$24.56
N/A
Revenue Growth
N/A
N/A
52 Week Low
$26.50
$13.37
52 Week High
$41.05
$57.50

Technical Indicators

Market Signals
Indicator
FDP
DNTH
Relative Strength Index (RSI) 63.59 53.85
Support Level $39.26 $45.64
Resistance Level $40.44 $53.33
Average True Range (ATR) 1.03 3.35
MACD 0.06 -0.60
Stochastic Oscillator 73.20 34.82

Price Performance

Historical Comparison
FDP
DNTH

About FDP Fresh Del Monte Produce Inc.

Fresh Del Monte Produce Inc is an integrated producer, marketer & distributor of fresh-cut fruit & vegetables. It operates in three segments, Fresh and value-added products segment, which includes pineapples, fresh-cut fruit, fresh-cut vegetables, melons, vegetables, non-tropical fruit, other fruit and vegetables, avocados, and prepared foods, Banana segment & Other products and services segment, including the third-party freight & logistic services business & the Jordanian poultry and meats business. The majority is from the Fresh and value-added products segment. Geographically, it operates in North America, Europe, Asia, the Middle East, and Other, out of which the highest is from North America.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: